About
Technology
Therapeutics
Partnering
Careers
Newsroom
Contact
Twitter
Linkedin
info@bighatbio.com
About
About
Technology
Technology
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Twitter
Twitter
Linkedin
Linkedin
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
4.24.2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
12.5.2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
Recent Posts
4.17.2025
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics
Press
3.4.2025
BigHat’s Next Chapter: A Message from CEO Peyton Greenside
Announcements
11.4.2024
Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Press
8.13.2024
BigHat featured on Genetic Engineering & Biotechnology News
Announcements
8.5.2024
BigHat named to the 2024’s Fierce Biotech 15
Announcements
6.27.2024
BigHat’s Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle Forward
Announcements
2.27.2024
BigHat’s CIO on Software Engineering Daily podcast
Announcements
10.26.2023
BigHat on Genetic Engineering & Biotechnology News
Press
8.2.2023
BigHat’s CSO on Biocom CA’s Lifelines Podcast
Announcements
6.8.2023
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023
Presentations
6.1.2023
BigHat Appoints John Corbin, PhD as Chief Development Officer
Announcements
12.21.2022
BigHat Year in Review 2022
Announcements
1 / 5
Next
© BigHat Bio 2023
.png)
